Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (8)

2024

  1. Novel Directed Enzyme Prodrug Therapy for Cancer Treatment Based on 2′-Deoxyribosyltransferase-Conjugated Magnetic Nanoparticles

    Biomolecules, Vol. 14, Núm. 8

2023

  1. p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins

    Cancers, Vol. 15, Núm. 7

2022

  1. Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study

    European Journal of Neurology, Vol. 29, Núm. 3, pp. 895-900

2021

  1. Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls

    Cells, Vol. 10, Núm. 1

  2. Multiplexed Biosensing Diagnostic Platforms Detecting Autoantibodies to Tumor-Associated Antigens from Exosomes Released by CRC Cells and Tissue Samples Showed High Diagnostic Ability for Colorectal Cancer

    Engineering, Vol. 7, Núm. 10, pp. 1393-1412

2020

  1. Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform

    Theranostics, Vol. 10, Núm. 7, pp. 3022-3034

2016

  1. Rapid endoglin determination in serum samples using an amperometric magneto-actuated disposable immunosensing platform

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 129, pp. 288-293

  2. Toward liquid biopsy: Determination of the humoral immune response in cancer patients using halotag fusion protein-modified electrochemical bioplatforms

    Analytical Chemistry, Vol. 88, Núm. 24, pp. 12339-12345